Pharmaceuticals · NYSE

LLYELI LILLY & Co

Last close
$1,443.50 +1.1%
52-week range
$850.51 to $1,460.00
Market cap
$1.36T
Next earnings
Not scheduled

Fiscal 2025 at a glance

Revenue
$65.2B
+45% vs FY24
Net income
$20.6B
+95% vs FY24
Free cash flow
$8.97B
+139% vs FY24
Net cash
-$35.2B
Cash $7.27B, debt $42.5B

Stock price

+2,027% since Dec 2016

Valuation vs its own 10 years

Above its 10-year median on all 4 multiples

Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.

P/E, trailing
46.8x
13.6x238x
60th percentile, above its median of 40.6x
Positive-earnings quarters only
Price / sales
15.7x
3.7x21.0x
92nd percentile, above its median of 8.3x
EV / EBITDA
37.7x
16.2x75.2x
75th percentile, above its median of 27.2x
Price / free cash flow
69.1x
25.0x3,182x
61st percentile, above its median of 55.2x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.

Valuation

P/E
46.8x
Earnings yield
2.1%
Price / sales
15.7x
Price / book
33.7x
Price / operating cash flow
44.3x
EV / EBITDA
37.7x
EV / sales
16.2x
Free cash flow yield
1.4%

Profitability

Gross margin
83.6%
Operating margin
n/a
Net margin
31.9%
Return on equity
68.5%
Return on capital
n/a

n/a: Not reported

Growth per year

Revenue, 3 years
+31.7%
Revenue, 5 years
+21.6%
Revenue, 9 years
+15.1%
EPS, 3 years
+49.3%

Balance sheet

Cash and investments
$4.88B
Total debt
$49.5B
Net cash
-$44.6B
Debt / equity
1.23x
Current ratio
1.39x

Shares and dividend

Shares outstanding
941M
Share count, 5 years
-1.4%
Beta, 1 year
0.30
Dividend yield
n/a
Dividend per share, TTM
n/a
Payout ratio
21.7%

n/a: No dividend

Ten years of the business

Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $24.4B
RevenueNet income
Gross profitLatest quarter $20.5B
EBITDALatest quarter $8.95B
Margins84 / 26%
GrossOperatingNet
Earnings per shareLatest quarter $7.22
Cash flowLatest quarter $11.4B
OperatingCapexFree
Cash vs debtLatest quarter $4.88B
Cash and investmentsTotal debt
P/E historyNow 46.8x
P/E, median 40.6x dashed
P/S historyNow 15.7x
P/S, median 8.3x dashed

Where the revenue comes from

Product went from 89% to 94% of revenue in 3 years

Share of revenue by product line, fiscal 2022 to 2025, as reported in the 10-K.

ProductCollaboration and Other Revenue
FY22
89%
$28.5B
FY23
84%16%
$34.1B
FY24
90%10%
$45.0B
FY25
94%
$65.2B
Fiscal 2025 by product line
Product lineRevenueSharevs FY24
Product$61.0B93.5%+50%
Collaboration and Other Revenue$4.22B6.5%-2%

Pharmaceuticals peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
LLY ELI LILLY & Co $1.36T +46% n/a46.8x15.7x 60th percentile
JNJ Johnson & Johnson $688B +8% n/a43.4x6.9x 90th percentile
MRK Merck & Co., Inc. $364B +5% n/a152x5.4x 98th percentile
PFE Pfizer Inc $165B +1% n/a41.2x2.6x 97th percentile
BMY Bristol Myers Squibb Co $130B +4% n/a14.1x2.6x 13th percentile
TEVA Teva Pharmaceutical Industries Ltd $51.9B -16% 10.2%103x3.7x Not enough history

The company

Sector
Health Care
Industry
Pharmaceuticals
CEO
David A. Ricks
Employees
38,350 (as of 2018)
Founded
1875
Headquarters
Indianapolis, IN
Fiscal year ends
December
Website
lilly.com

What it does

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about LLY.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 4,308 active funds. Crowd level: quiet.

Open the Smart money tab